Research and Markets
Dealmaking and Industry Outlook: Antivirals - Available Now
Published in AIDS Weekly, June 22nd, 2009
The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral development. Viruses originated early during the evolution of life and have survived by their ability to mutate key genetic sequences in order to evade the defense systems of their hosts.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-06-22)
More Articles from AIDS Weekly
- McGill University
HIV-1's 'hijacking mechanism' pinpointed by McGill/JGH researchers - Rockefeller University Press
Muscle atrophy through thick but not thin - HIV/AIDS
New findings in HIV/AIDS described by F.G. Hermann and co-researchers - HIV/AIDS
Research conducted at National Cancer Institute has updated our knowledge about HIV/AIDS - HIV/AIDS
Research data from E.R. Jennyavital and colleagues update understanding of HIV/AIDS - HIV/AIDS
Research from D.A. Degoey and colleagues has provided new data on HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
